Loss of 11q and 16q in Wilms tumors is associated with anaplasia, tumor recurrence, and poor prognosis
- 10 November 2006
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 46 (2), 163-170
- https://doi.org/10.1002/gcc.20397
Abstract
Allele loss of chromosome arms 11q and 16q in Wilms tumors has been associated with different clinical parameters in prior studies. To substantiate these findings in a large collection of tumors treated according to the GPOH/SIOP protocol and to narrow down critical regions, we performed loss of heterozygosity (LOH) analyses of chromosome arms 11q and 16q on 225 Wilms tumors. On chromosome arm 11q an overall rate of allele loss of 19.6% (44 of 225 tumors) was found using eleven markers that were almost evenly distributed along the long arm. Chromosome arm 16q was analyzed with six markers selected from gene‐rich regions that identified an LOH rate of 18.4% (41/223). Evaluation of LOH with respect to clinical data revealed significant associations of LOH 11q with histology: LOH 11q was 3–4 times more frequent in mixed type and diffuse anaplastic tumors. In contrast, epithelial as well as stromal type tumors never exhibited allele loss on 11q. Furthermore, a significant correlation with tumor recurrence and death was detected, but only for tumors that lost the entire long arm of chromosome 11. Similarly, LOH 16q was correlated with higher risks of later relapse, especially in tumors with complete loss of the long arm. Hence, analyses of LOH on 11q and 16q appear to be helpful to identify tumors with a higher risk of relapse and adverse outcome, which need adjusted therapeutic approaches.Keywords
This publication has 18 references indexed in Scilit:
- Loss of Heterozygosity for Chromosomes 1p and 16q Is an Adverse Prognostic Factor in Favorable-Histology Wilms Tumor: A Report From the National Wilms Tumor Study GroupJournal of Clinical Oncology, 2005
- Success of clinical trials in childhood Wilms' tumour around the worldThe Lancet, 2004
- Wilms Tumor and the WT1 GeneExperimental Cell Research, 2001
- Gain of 1q Is Associated with Adverse Outcome in Favorable Histology Wilms’ TumorsThe American Journal of Pathology, 2001
- Microdissecting the Genetic Events in Nephrogenic Rests and Wilms' Tumor DevelopmentThe American Journal of Pathology, 1998
- Allele loss in Wilms tumors of chromosome arms 11q, 16q, and 22q correlates with clinicopathological parametersGenes, Chromosomes and Cancer, 1998
- Clinicopathologic correlates of loss of heterozygosity in Wilms' tumor: A preliminary analysisMedical and Pediatric Oncology, 1996
- Mapping of a Putative Tumor Suppressor Locus to Proximal 7p in Wilms TumorsGenomics, 1996
- Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locusCell, 1990
- Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumpingNature, 1990